Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Nontraditional manifestations of primary hyperparathyroidism.

Walker MD, Rubin M, Silverberg SJ.

J Clin Densitom. 2013 Jan-Mar;16(1):40-7. doi: 10.1016/j.jocd.2012.11.008. Review.

2.

Asymptomatic primary hyperparathyroidism.

Silverberg SJ, Walker MD, Bilezikian JP.

J Clin Densitom. 2013 Jan-Mar;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005. Review.

3.

Cardiovascular aspects of primary hyperparathyroidism.

Walker MD, Silverberg SJ.

J Endocrinol Invest. 2008 Oct;31(10):925-31. Review.

PMID:
19092300
4.

Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Walker MD, Rundek T, Homma S, DiTullio M, Iwata S, Lee JA, Choi J, Liu R, Zhang C, McMahon DJ, Sacco RL, Silverberg SJ.

Eur J Endocrinol. 2012 Aug;167(2):277-85. doi: 10.1530/EJE-12-0124. Epub 2012 Jun 1.

5.

An overview of normocalcemic primary hyperparathyroidism.

Pawlowska M, Cusano NE.

Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):413-21. doi: 10.1097/MED.0000000000000198. Review.

PMID:
26512768
6.

[Renal function in primary hyperparathyroidism].

Borretta G, Gianotti L, Cesario F, Borretta V, Tassone F.

G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S91-5. Italian.

PMID:
20922703
7.

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP.

J Clin Endocrinol Metab. 2014 Oct;99(10):3580-94. doi: 10.1210/jc.2014-1415. Epub 2014 Aug 27.

8.

Interdisciplinary Aspects of Primary Hyperparathyroidism: Symptomatology in a Series of 100 Cases.

Jodkowska A, Tupikowski K, Szymczak J, Bohdanowicz-Pawlak A, Bolanowski M, Bednarek-Tupikowska G.

Adv Clin Exp Med. 2016 Mar-Apr;25(2):285-93. doi: 10.17219/acem/42626.

9.

Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Gasser RW.

Wien Med Wochenschr. 2013 Sep;163(17-18):397-402. doi: 10.1007/s10354-013-0235-z. Epub 2013 Aug 29. Review.

PMID:
23990260
10.

Nonclassical symptoms of primary hyperparathyroidism and their response to parathyroidectomy.

Alex G, Morris L, Pasieka J, Perrier N.

Am Surg. 2013 Apr;79(4):337-43. Review.

PMID:
23574840
11.

Should 'mild primary hyperparathyroidism' be reclassified as 'insidious': is it time to reconsider?

Macfarlane DP, Yu N, Donnan PT, Leese GP.

Clin Endocrinol (Oxf). 2011 Dec;75(6):730-7. doi: 10.1111/j.1365-2265.2011.04201.x. Review.

PMID:
21848908
12.

Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis.

McMahon DJ, Carrelli A, Palmeri N, Zhang C, DiTullio M, Silverberg SJ, Walker MD.

J Clin Endocrinol Metab. 2015 Dec;100(12):4399-407. doi: 10.1210/jc.2015-3202. Epub 2015 Oct 7. Review.

13.

Primary hyperparathyroidism--is mild disease worth treating?

Gittoes NJ, Cooper MS.

Clin Med (Lond). 2010 Feb;10(1):45-9. Review.

PMID:
20408307
14.

The diagnosis and management of asymptomatic primary hyperparathyroidism.

Silverberg SJ, Bilezikian JP.

Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):494-503. Review.

PMID:
16957763
15.

Non-classical target organs in primary hyperparathyroidism.

Silverberg SJ.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N117-25. Review.

PMID:
12412788
16.

Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.

Tordjman KM, Yaron M, Izkhakov E, Osher E, Shenkerman G, Marcus-Perlman Y, Stern N.

Eur J Endocrinol. 2010 May;162(5):925-33. doi: 10.1530/EJE-09-1067.

17.

Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.

Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE.

Surgery. 2009 Dec;146(6):1116-22. doi: 10.1016/j.surg.2009.09.034. Epub 2009 Oct 30.

PMID:
19879613
18.

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR.

J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi: 10.1210/jc.2008-1760. Review.

19.

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C.

J Clin Endocrinol Metab. 2007 Aug;92(8):3114-21. Epub 2007 May 29.

PMID:
17535997
20.

Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Trombetti A, Christ ER, Henzen C, Gold G, Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, Meier C.

J Endocrinol Invest. 2016 May;39(5):567-76. doi: 10.1007/s40618-015-0423-3. Epub 2016 Jan 7.

PMID:
26742935

Supplemental Content

Support Center